Optimizing Re-Irradiation for Head and Neck Cancer
Author Information
Author(s): Schleifenbaum Julia Katharina, Morgenthaler Janis, Sharma Shachi Jenny, Klußmann Jens Peter, Linde Philipp, Wegen Simone, Rosenbrock Johannes, Baues Christian, Fokas Emmanouil, Khor Richard, Ng Sweet Ping, Marnitz Simone, Trommer Maike
Primary Institution: University Hospital Cologne
Hypothesis
What are the impacts of dose-escalation, salvage surgery, PEG tube, and biomarkers on outcomes for patients with locally recurrent head and neck cancer?
Conclusion
Key prognostic factors include the presence of a PEG tube and inflammation status, with salvage surgery being the preferred treatment option.
Supporting Evidence
- 62% of patients were radiotherapy-naïve.
- Median overall survival for initial RT was 24 months, while for re-RT it was 12 months.
- Patients with UICC grade IV tumours had significantly shorter OS.
- Salvage surgery before RT was a positive prognostic factor for OS.
Takeaway
This study looked at patients with head and neck cancer that came back after treatment. It found that some factors, like needing a feeding tube, can make things worse, while surgery can help.
Methodology
Retrospective analysis of 101 patients treated with radiotherapy, radio-chemotherapy, or radio-immunotherapy between 2010 and 2018.
Potential Biases
Potential biases due to retrospective data collection and single-center analysis.
Limitations
Single center study limits generalizability; retrospective design may have incomplete data.
Participant Demographics
Patients included were primarily male (approximately 73%) with a median age of 64.5 years.
Statistical Information
P-Value
p<0.01
Confidence Interval
CI 12.08; 26.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website